Palvella Therapeutics Highlights Continued Progress Across Rare Skin Disease Pipeline with Two Poster Presentations at the 2026 American Academy of Dermatology Annual Meeting
Poster #76954 highlights QTORIN™ rapamycin’s single phase anhydrous gel formulation designed to…
Crescel Reports Positive Randomized Controlled Trial Results for Biobotanical Skin Renewal Cream in Rosacea
Study Shows Greater Clinical Improvement vs. Metronidazole-Based Standard of Care with Favorable TolerabilityMIAMI…
Skin Aesthete Becomes Navi Mumbai’s Only Clinic to Offer EMFACE, Redefining Non-Invasive Facial Rejuvenation
MUMBAI, India, Feb. 3, 2026 /PRNewswire/ -- Skin Aesthete, the premium dermatology…
Clarins introduces the AI Skin Observer, in-store skin diagnosis augmenting human touch with the best of AI and Beauty Tech
PARIS, Jan. 22, 2026 /PRNewswire/ -- Faithful to its pioneering spirit since…
Celularity CEO Comments on Centers for Medicare & Medicaid Services Withdrawal of Skin Substitute Local Coverage Determinations
While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage…
CeraVe Supports Global Skin Health Leaders to Deliver Care to Underserved Patients on World Skin Health Day
In Partnership with the International League of Dermatological Societies (ILDS) and the…
Dimora PHMB Skin and Wound Cleanser – Gentle for Kids, Trusted by Parents
SAN FRANCISCO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Dimora Medical is proud…
CeraVe Celebrates Two Decades of “Developed with Dermatologists” Skincare: A 20th Birthday Tribute to Skin Barrier Science and Innovations
A Global Celebration Unites Dermatologists, Influencers, and Innovators in New York City…
Dupixent (dupilumab) Data at Revolutionizing Atopic Dermatitis (RAD) Conference Reinforce Use in Atopic Dermatitis Patients with Skin of Color
Atopic dermatitis is a chronic disease that disproportionately impacts communities of color…
Acclaro Medical Raises $23 Million in Series B Funding Led by Accelmed Partners to Advance Groundbreaking 2910 nm Fiber Laser Technology
Accelmed $20 Million Investment with 3E Bioventures Capital Funding of $3 Million…
